Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study

Anne Kirstine Hundahl Møller; Karen Damgaard Pedersen; A. Gothelf; G. Daugaard

doi:10.3109/02841860903544592

Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study

Anne Kirstine Hundahl Møller, Karen Damgaard Pedersen, A. Gothelf, G. Daugaard

13 Citations (Scopus)

Abstract

Background. The present study was conducted to evaluate the efficacy and toxicity of a combination of paclitaxel, cisplatin and gemcitabine in patients with carcinoma of unknown primary site (CUP). Patients and methods. Patients with CUP, ECOG performance status 0-1 and age between 18 and 65 years old were treated with paclitaxel 175 mg/m

Original language	English
Journal	Acta Oncologica
Volume	49
Issue number	4
Pages (from-to)	423-430
Number of pages	8
ISSN	0284-186X
DOIs	https://doi.org/10.3109/02841860903544592
Publication status	Published - 2010

Access to Document

10.3109/02841860903544592

Cite this

@article{9abe00fe686e4f07969d6e4c375cd6e5,

title = "Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study",

abstract = "Background. The present study was conducted to evaluate the efficacy and toxicity of a combination of paclitaxel, cisplatin and gemcitabine in patients with carcinoma of unknown primary site (CUP). Patients and methods. Patients with CUP, ECOG performance status 0-1 and age between 18 and 65 years old were treated with paclitaxel 175 mg/m",

author = "M{\o}ller, \{Anne Kirstine Hundahl\} and Pedersen, \{Karen Damgaard\} and A. Gothelf and G. Daugaard",

year = "2010",

doi = "10.3109/02841860903544592",

language = "English",

volume = "49",

pages = "423--430",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "4",

}

TY - JOUR

T1 - Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study

AU - Møller, Anne Kirstine Hundahl

AU - Pedersen, Karen Damgaard

AU - Gothelf, A.

AU - Daugaard, G.

PY - 2010

Y1 - 2010

N2 - Background. The present study was conducted to evaluate the efficacy and toxicity of a combination of paclitaxel, cisplatin and gemcitabine in patients with carcinoma of unknown primary site (CUP). Patients and methods. Patients with CUP, ECOG performance status 0-1 and age between 18 and 65 years old were treated with paclitaxel 175 mg/m

AB - Background. The present study was conducted to evaluate the efficacy and toxicity of a combination of paclitaxel, cisplatin and gemcitabine in patients with carcinoma of unknown primary site (CUP). Patients and methods. Patients with CUP, ECOG performance status 0-1 and age between 18 and 65 years old were treated with paclitaxel 175 mg/m

UR - https://www.scopus.com/pages/publications/77951217280

U2 - 10.3109/02841860903544592

DO - 10.3109/02841860903544592

M3 - Journal article

C2 - 20397773

SN - 0284-186X

VL - 49

SP - 423

EP - 430

JO - Acta Oncologica

JF - Acta Oncologica

IS - 4

ER -

Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study

Abstract

Access to Document

Other files and links

Cite this